MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • 2024 International Congress

    Apathy in de novo Parkinson’s disease improves after the first years with dopaminergic treatment.

    A. Castrioto, M. Anheim, E. Schmitt, S. Meoni, JL. Houeto, H. Klinger, D. Sourd, P. Pelissier, E. Lhommee, C. Tranchant, JP. Azulay, F. Durif, E. Moro, V. Fraix, S. Thobois, P. Krack (Grenoble, France)

    Objective: to define the evolution of apathy and other neuropsychiatric symptoms in patients with early Parkinson’s disease (PD). Background: Apathy is a common neuropsychiatric symptom…
  • 2024 International Congress

    The comorbidity conundrum in functional movement disorder: How are FMD patients with additional other FND different?

    S. Desai, A. Shah, D. Desai (Anand, India)

    Objective: This study aimed to compare patients with isolated Functional Movement Disorders [FMD-i] to those with associated co-morbid other Functional Neurological Disorders(FND) [FMD+]. Background: FMD…
  • 2024 International Congress

    Phenomenology of Functional Movement Disorders in Children

    A. Cherian, D. Kalikavil Puthanveedu (Thiruvananthapuram, India)

    Objective: To study the phenomenology of Functional Movement Disorders (FMD) in children. Background: Data on FMD in children is sparse Method: The study included 13…
  • 2024 International Congress

    Neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy in reference centers of Valle del Cauca- Colombia

    V. Martínez-Villota, L. Ortega-Bolaños, C. Hurtado-Gonzalez (Pasto, Colombia)

    Objective: To evaluate the neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy attended in reference centers  of the Valle del Cauca, Colombia, between 2020 and…
  • 2024 International Congress

    Reliability and Validity of the English Version of the Parkinson Anxiety Scale

    J. Lam, X. Tang, D. Meng, P. Uzelman, F. Pio, N. Ainsworth, F. Vila-Rodriguez, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To evaluate the reliability and validity of the English version of the Parkinson Anxiety Scale (PAS) in patients with Parkinson’s disease (PD). Background: The…
  • 2024 International Congress

    Assessment Of The Effect Of Sleep Deprivation And Essential Amino Acid Deficient Diet (Tryptophan) On Growth And Cognition In Wistar Rats

    L. Usman, R. Ibrahim, H. Abdulameed, E. Ajani, A. Akinmoladun (Kepala Batas, Malaysia)

    Objective: This study explores the interplay encompassing amino acids' roles, metabolic processes, growth, and the intricate relationships between sleep patterns, amino acid-deficient diet, and caffeine…
  • 2024 International Congress

    Improving Neuropsychiatric Comorbidity in Geriatric Spinocerebellar Ataxia

    M. Le, B. Carr (Gainesville, USA)

    Objective: This study evaluates neuropsychiatric comorbidity in spinocerebellar ataxia (SCA) and highlights key aspects of management in the geriatric population. It discusses efficacy of neuropsychotropic…
  • 2024 International Congress

    The assessment of anxiety and depression comorbidities and the DRN electrophysiology in a primate model of Parkinson’s Disease

    A. Sadoun, M. Deffains, Q. Li, E. Bezard, F. Georges, E. Pioli (Floirac, France)

    Objective: The study aimed to examine the anxiety/depression-like phenotype and the potential role of dorsal raphe nucleus (DRN) in the gold standard primate model of…
  • 2024 International Congress

    A Randomized, Double-Blind, Placebo-Controlled Trial of a Multi-Strain Probiotic for Anxiety in Parkinson’s Disease

    J. Lam, P. Uzelman, J. Zhu, D. Meng, F. Pio, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To evaluate the effect of a multi-strain probiotic on anxiety in patients with Parkinson’s disease (PD). Background: There is a lack of dedicated randomized…
  • 2024 International Congress

    Investigating an Emerging Anxiety-like Phenotype in a Novel Bilateral Rodent Model of Parkinsonian Alpha-Synuclein Pathology

    N. Lipari, I. Sandoval, F. Manfredsson, C. Bishop (Binghamton, USA)

    Objective: Investigate an emerging anxiety-like phenotype at various timepoints in a novel bilateral rodent model of parkinsonian alpha-synuclein pathology. Background: Parkinson’s Disease (PD) anxiety poses…
  • 1
  • 2
  • 3
  • …
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley